GLENMARK LIFE SCIENCES IPO INFORMATION & GMP DETAILS:
Glenmark Life Science Main Products are a Manufacturer of Medicine and Other Pharma Products. Glenmark Life Science Main Medicine Is pain, diabetes, gastrointestinal, anti-infectives, and other Medicine Manufacturer. This Company Also Work In Pharma Marketing In All Over India. Glenmark IPO Open This Week.
GLENMARK LIFE SCIENCES COMPANY PLACE:
Company Manufacturer Unit In Ankleshwar, Dahej, Mohol, And Kurkumbh. This Is a Big Medicine Manufacture Company In India. This Company Is Profitable in His Sector. Company Supply Medicine in the United Kingdom, Finland, Romania, Mexico, Canada, South Korea, And Other Countries.
Glenmark Life Science Big Manufacture Plant Available In India. 725.8 KL Manufacturer Capacity Available in This Company. This Company Supply Medicine All Over India and Some Big Countries. Big Player Company In This Sector. Glenmark Company Manufacturer Medicine and Also Selling Medicine. Big Investor and Promoters are Available in Glenmark Life Science.
PLUS FUNDA OF GLENMARK LIFE SCIENCES:
- Millions of Agency Network Available.
- Largest Distribution All Over India and Other Countries.
- Focus on Giving Quality Medicine.
- Good Management is available and a Strong Global Network Available.
NUMBERS OF PROMOTERS AVAILABLE IN GLENMARK LIFE SCIENCES:
- Glenmark Life Science Ltd.
- HSBC Investment.
- Kuber India.
- Reliance Insurance.
- Copthall Mauritius Investor.
- Government Investor.
Opinion Of Crachza Team:- Good Promoters Are Available In Glenmark Life Science. Give Good Returns in Long-Terms. So Keep Your Eyes. (Note:- This Is Only Information And Knowledge Purpose)
GLENMARK LIFE SCIENCES FINANCIAL REPORT:
| REPORT | FY2019 | FY2020 | FY2021 |
| Assets | 14,753 | 17,256 | 19,970 |
| Revenue | 8,868 | 15,493 | 18,859 |
| Profit After Tax | 1,955 | 3,130 | 3,515 |
Source: Glenmark Life Science Financial Report.
GLENMARK LIFE SCIENCE IPO DETAILS:
| IPO Open Date | Jul 27, 2021 |
| IPO Close Date | Jul 29, 2021 |
| Type Of Issue | Book Built IPO |
| Value | ₹2 |
| Price Of IPO | ₹695 to ₹720 Per share |
| Lot Size | 20 |
| Min Quantity | 20 |
| Listing Platform | BSE, NSE |
| Size Issue | ₹1513.60 Cr |
| Fresh Issue | 1060 Cr |
| Sale Price | ₹453.60 Cr |
This IPO Is Good IPO Coming In Indian Gray Market. This Sector IPO Performed Good. QIB, NII, RII Subscribe This IPO By Low at This Moment Price. This IPO Issue Size is ₹1513.60 Cr and the Fresh Issue Size is 1060 Cr. Glenmark Life Science Issue Sale Price Is 453.60 Cr.
Glenmark Life Science Is a Profitable Medicine Company. Glenmark Life Science Is Give Good Profit. This IPO Is Last Good IPO in This Month.
GLENMARK LIFE SCIENCE IPO SCHEDULE:
| Open Date | 27/07/2021 |
| Close Date | 29/07/2021 |
| Allotment Date | 03/07/2021 |
| Refunds | 04/07/2021 |
| Credit Stock In Account | 05/07/2021 |
| Listing Date | 06/07/2021 |
GLENMARK LIFE SCIENCE IPO Open Date is 27 JULY and Close Date Is 29 JULY. Allotment Date of This IPO Is Aug 3 and Refund Is Unblock In Bank Account Aug 4. Stock Credit In Demate Account on Aug 5 Than Glenmark Life Science Is Listing In BSE and NSE Platform on Aug 6, 2021. Trading Start in This Company at 10:00 am.
GLENMARK LIFE SCIENCE IPO LOT SIZE DETAILS:
This IPO Min Lot Size 1 (20 Quantity in one Lot) and Price of One Lot (695 to 720) So Total Amount is (13900 to 14400).
Max Lot Size 13 (20 Quantity in one Lot) Total Amount Is (180,700 to 187,200).
This Company is one of the Good Medicine Companies Listed on BSE and NSE So This Company Give Good Returns for its Share Holders. This Is a Good Future Profitable Company. Big Stock Player Also Invested in Glenmark Life Science and According To Rumors Investor are h0ld This Stock For Long Term.
GLENMARK LIFE SCIENCE IPO SUBSCRIBE DETAILS:
Live Update(28/09/2021) Time (12:00)
| Category | IPO Subscribe Rate |
| QIB (Qualified Institutional Buyer) | 36.97 MULTIPLE TIME |
| NII (Non-Institutional Investor) | 122.54 MULTIPLE TIME |
| RII (Retail Individual Investor) | 14.63 MULTIPLE TIME |
| Total Subscribe | 44.17 MULTIPLE TIME |
GLENMARK LIFE SCIENCE GRAY MARKET PREMIUM:
Glenmark Life Science Today Gray Market Premium Is 120 Rupees Is So Avg Premium Rate. Around 21% Premium Running. Premium Rate Are Going Avg in This IPO.
How To Check IPO Allotment Details:
Link Available on Below
Glenmark Life Science IPO Allotment Check By BSE Website:- Not Available
Glenmark Life Science Partner Company Website:- Not Available
Check IPO Details Easily.
#Note:- This All Content Provide Only Education And Information Purpose. We Are Not Trade-In Gray Market. We Are Provide Only Information. Consult Your Advisor Before Investing.